Do Tumor de Células de Sertoli-Leydig à Inversão Uterina e à Insuficiência Ovariana Prematura

Dear Editor,
We report a rare clinical case of Sertoli-Leydig cell tumor (SLCT) culminating in uterine inversion. These tumors represent less than 0.2% of primary ovarian tumors and present diagnostic and therapeutic challenges due to their rarity, heterogeneous clinical presentation, and risk of malignancy. The definitive diagnosis is histopathological. First-line treatment is surgical. Adjuvant chemotherapy and radiotherapy may be indicated. The prognosis depends on the histological subtype and disease stage. Non-puerperal uterine inversion, with multifactorial pathophysiology and morbidity, is a rare gynecological complication. Aggressive behavior and size of the SLCT may contribute to uterine inversion.

Clique aqui para aceder ao artigo completo (em inglês).

Este site utiliza cookies para permitir uma melhor experiência por parte do utilizador. Ao navegar no site estará a consentir a sua utilização.